Polygenic risk for white matter hyperintensities is associated with early cerebrovascular events partly through hemodynamic measures in cognitively unimpaired middle-aged and older adults with low cardiovascular risk.


Por: Genius P, Rodríguez-Fernández B, Minguillon C, Brugulat-Serrat A, Huguet J, Esteller M, Sudre CH, Cortés Canteli M, Tristão-Pereira C, García Lunar I, Navarro A, Gispert JD and Vilor-Tejedor N

Publicada: 5 ene 2026 Ahead of Print: 5 ene 2026
Resumen:
BACKGROUND: White matter hyperintensities (WMH) are a hallmark of cerebrovascular disease. They are often found in middle-aged individuals and are associated with a greater risk of stroke and vascular dementia. Although traditional cardiovascular risk factors are linked to WMH, some individuals with low vascular risk according to conventional scales still show WMH burden, suggesting an increased vulnerability. This study aimed to elucidate the biological mechanisms underlying the presence of WMH in cognitively unimpaired (CU) middle-aged and older individuals with low cardiovascular risk. METHODS: We included 1,072 CU participants from the ALFA study with a low cardiovascular risk profile for late-life dementia (CAIDE-I score  =  9). We defined a multi-stage exploratory study design to reveal the potential biological pathways driving WMH in the study sample. First, we estimated the genetic predisposition to WMH using polygenic scoring (PRS(WMH)) and used this score as a predictor of: (a) WMHV as a subclinical quantitative measure of global and regional WMH burden and (b) pathological WMH levels (pathological: Fazekas score  =  2), as a qualitative measure of clinically relevant WMH. Covariate-adjusted Spearman's rank correlation tests evaluated the association between the PRS(WMH) and regional and global WMH volumes (WMHV), while a logistic regression model was performed to explore the association with pathological WMH. Second, group-stratified partial correlations (CAIDE-specific factors) were explored to identify homogeneous groups with persistent genetic associations with WMH, beyond the presence of cardiovascular risk factors. Third, an enrichment analysis of the PRS-annotated genes unveiled the biological mechanisms leading to WMH burden. Finally, based on the enrichment analysis, we examined the role of cardiometabolic traits as biomarkers of WMHV. RESULTS: Genetic predisposition to WMH was associated with larger global and regional WMHV after adjusting for age and sex, specifically in frontal areas. In this group, larger WMHV were associated with poorer executive function. Group-stratified analyses showed significant correlations particularly among older participants, those with hypercholesterolemia and those with lower educational attainment. Gene-set enrichment involved vascular, neuronal and cellular pathways, and blood pressure measurements partially mediated the association between the genetic risk for WMH and the actual WMHV. INTERPRETATION: These findings support a polygenic contribution to cerebrovascular burden and nominate cardiac function as a biological link along the heart-brain axis. While the PRS(WMH) is not yet clinically actionable, our results propose and prioritize hemodynamic monitoring as an early, testable intervention in genetically susceptible individuals, to help prevent cerebrovascular damage and downstream cognitive impairment in healthy participants with low cardiovascular risk profile.

Filiaciones:
Genius P:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Hospital del Mar Medical Research Institute, Barcelona, Spain

 Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain

 Doctoral School, PhD Programme in Bioinformatics, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain

Rodríguez-Fernández B:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Hospital del Mar Medical Research Institute, Barcelona, Spain

 Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain

 Autonomous University of Barcelona, Barcelona, Spain

Minguillon C:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Hospital del Mar Medical Research Institute, Barcelona, Spain

 Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain

Brugulat-Serrat A:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Hospital del Mar Medical Research Institute, Barcelona, Spain

 Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain

 Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, United States

Huguet J:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

:
 Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain

 Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

 Department of Physiological Sciences, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain

 Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain

Sudre CH:
 MRC Unit for Lifelong Health and Ageing, Department of Population Science and Experimental Medicine, University College London, London, United Kingdom

 Hawkes Institute, Department of Computer Science, University College London, London, United Kingdom

 Department of Neurodegenerative Disease, The Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom

 School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom

Cortés Canteli M:
 Centro Nacional de Investigaciones Cardiovasculares (CNIC), Fuencarral-El Pardo, Madrid, Spain

 Centro de Neurociencias Cajal - Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain

Tristão-Pereira C:
 Centro Nacional de Investigaciones Cardiovasculares (CNIC), Fuencarral-El Pardo, Madrid, Spain

García Lunar I:
 Centro Nacional de Investigaciones Cardiovasculares (CNIC), Fuencarral-El Pardo, Madrid, Spain

 Department of Cardiology, University Hospital La Moraleja, CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain

Navarro A:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain

 Department of Experimental and Health Sciences, Institute of Evolutionary Biology (CSIC-UPF), Universitat Pompeu Fabra, Barcelona, Spain

 Institute of Evolutionary Biology (CSIC-UPF), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain

Gispert JD:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Hospital del Mar Medical Research Institute, Barcelona, Spain

 Centro Nacional de Investigaciones Cardiovasculares (CNIC), Fuencarral-El Pardo, Madrid, Spain

 Centro de Investigación Biomédica en Red Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain

Vilor-Tejedor N:
 Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain

 Hospital del Mar Medical Research Institute, Barcelona, Spain

 Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain

 Department of Genetics, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

 Institute for Risk Assessment Sciences (IRAS), Department of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
ISSN: 16642295





Frontiers in Neurology
Editorial
Frontiers Media S.A., AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 16 Número:
Páginas: 1667424-1667424
WOS Id: 001662969500001
ID de PubMed: 41561329
imagen Green Submitted, gold

MÉTRICAS